Contract research organizations (CROs) and contract testing labs can now access high-resolution single-cell protein analysis with the Pixelgen Proxiome Kit. This new technology enables detailed spatial mapping of immune cell proteins, delivering critical insights for drug discovery, biomarker identification, and immunotherapy research.
Powered by Proximity Network Assay technology, the Pixelgen Proxiome Kit, Immuno 155 provides a nanoscale view of protein interactions with a validated 155-protein panel. Labs can analyze up to 50,000 proteins per cell with an average resolution of 50 nanometers, gaining deeper insights into protein clustering, colocalization, and cell-cell interactions.
Benefits for Contract Testing Labs and CROs:
- Enhanced drug development: High-resolution protein interactome mapping improves target validation.
- Accelerated biomarker discovery: Nanoscale analysis uncovers novel disease markers.
- Robust data generation: Single-cell resolution delivers deeper insights for precision medicine.
- Instrument-free workflow: Cost-effective and easy to integrate into existing lab workflows.
- Versatile sample support: Compatible with PBMCs, bone marrow, cell lines, and organoids.
With the Pixelgen Proxiome Kit, CROs and contract testing labs can provide next-generation proteomics services, strengthening their capabilities in precision medicine and immune research.
This article has been sourced from a press release and may include content created or refined using AI tools and verified by our editorial team. For the full press release, visit: Pixelgen Technologies
